L
Overview
Liminal (Menyala) supports high-potential founders by co-building companies and providing funding to move ideas toward Series B and beyond. It combines build expertise, preferential access to resources, and capital to reduce early-stage risk. Led by serial founders and backed by Temasek, the firm operates from Singapore and Boston, offering hands-on development along with funding to help founders scale. Its approach differentiates itself through the Founders’ Studio model that pairs hands-on execution with investor backing, giving startups an integrated path from concept to growth.
Work here?Claim your company
Simplify's take
What believers are saying
- Liminal backed Genie Health's US$3 million seed on October 21, 2026.
- Tally partnered with Liminal on July 22, 2026 to attack healthcare billing.
- Liminal launched MCP on August 25, 2026, strengthening its enterprise AI platform story.
What critics are saying
- Liminal's studio model depends on repeatable founder supply; weak pipeline kills growth by 2027.
- Tally's July 2026 partnership is only a collaboration, not proof of durable revenue.
- Competing venture studios and incumbents can copy the build-services playbook and compress margins.
What makes Liminal (Menyala) unique
- Temasek-backed Liminal co-builds companies from idea to Series B with operating talent.
- Liminal combines capital, product, and recruiting under one studio, not passive venture investing.
- Its portfolio spans healthcare, identity, fraud, and cybersecurity, signaling cross-regulated-domain building.
Help us improve and share your feedback! Did you find this helpful?